Business Context and Reporting Period
This Form 8-K is filed by East Resources Acquisition Company (not Abacus Global Management, Inc.) for the reporting period of April 6, 2021. The registrant is a Delaware corporation with securities trading on The NASDAQ Stock Market LLC under the symbols ERESU, ERES, and ERESW.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and listing compliance rather than financial performance.
Material Changes
The primary material event is the death of Allen F. Sobol, a member of the Board of Directors, on April 4, 2021. Mr. Sobol served as an independent director, chairman of the Audit Committee, and a member of the Compensation Committee. Consequently, the Company is temporarily not in compliance with Nasdaq Listing Rules regarding:
- Board composition (majority of directors must be independent).
- Audit Committee composition (must have at least three independent directors).
- Compensation Committee composition (must have at least two independent directors).
Outlook, Risks, and Management Commentary
Management has notified Nasdaq of the non-compliance. The Company has an automatic cure period under Nasdaq Listing Rules 5605(b)(1)(A), 5605(c)(4), and 5605(d)(4). The Company expects to regain compliance by appointing a new independent director to fill the vacancy on the Board, Audit Committee, and Compensation Committee before the cure period expires. No other risks, contingencies, or unusual items are disclosed in this filing.
Investor Verification Checklist
- Verify the appointment of a new independent director to restore Board and committee compliance.
- Confirm the timeline for the new director's appointment relative to the Nasdaq cure period expiration.
- Review subsequent filings for updates on the Board composition and any changes to the Audit or Compensation Committees.